Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4586155 | 0.93 | ADRB3 (0.49) | ADRB3ADRB1 | |
| SCHEMBL4586147 | 0.93 | ADRB3 (0.49) | ADRB3ADRB1 | |
| SCHEMBL4582768 | 0.90 | ADRB3 (0.54) | ADRB3ADRB1 | |
| SCHEMBL4582771 | 0.90 | ADRB3 (0.54) | ADRB3ADRB1 | |
| SCHEMBL4584928 | 0.87 | ADRB3 (0.59) | ADRB3ADRB1 | |
| SCHEMBL4584934 | 0.87 | ADRB3 (0.59) | ADRB3ADRB1 | |
| SCHEMBL4585333 | 0.86 | ADRB3 (0.54) | ADRB3ADRB1 | |
| SCHEMBL4585328 | 0.86 | ADRB3 (0.54) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL4584120 | 0.85 | ADRB3 (0.59) | ADRB3ADRB1 | |
| Hydrochloric Acid SCHEMBL4584123 | 0.85 | ADRB3 (0.59) | ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417060-B2 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2008-08-26 | — | — | US | disclosed |
| US-20050137236-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137236-A1 | Aminoalcohol derivatives | GPR39, PRMT9, CHRM2 | ADRB3 86/4885ADRB1 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.